Showing 5 posts of 140 posts found.

Money trap

Drug development: where’s the added investment value?

February 18, 2010
Research and Development CRO, Les Rose, R&D, biotech, funding

Venture capital is a curious business. The global financial crisis which we are slowly emerging from has exposed some rather …

Get the best from your R&D team

December 6, 2006
Business Services, Research and Development R&D, recruitment

One of the key drivers of much of the recent merger and acquisition activity within the pharmaceutical industry is the …

R&D Scoreboard poor gauge of pharma investment in the UK

November 8, 2005
Research and Development AstraZeneca, GSK, Pfizer, R&D, R&D scoreboard

 The R&D Scoreboard is fundamentally flawed as a measure of R&D investment in the UK and pharmaceutical companies are continuing …

Pharma continues to invest in UK research and development

October 24, 2005
Sales and Marketing Pfizer, R&D

 UK pharma and biotech companies increased R&D investment by 4% in the last year, according to the latest government figures.The …

Commercial and R&D: reinventing the relationship

October 17, 2003
Research and Development R&D, commercial

Traditionally, pharma companies have been run as research-based organisations relying on well-integrated internal R&D capabilities to feed their commercial pipelines …

Latest content